Literature DB >> 10533758

Complications after bilateral adrenalectomy for phaeochromocytoma in multiple endocrine neoplasia type 2--a plea to conserve adrenal function.

J S de Graaf1, R P Dullaart, R P Zwierstra.   

Abstract

OBJECTIVE: To evaluate the complications of the adrenocortical supplementation that is needed after bilateral adrenalectomy for phaeochromocytoma in patients with multiple endocrine neoplasia (MEN) type 2 syndrome.
DESIGN: Retrospective study.
SETTING: University hospital, The Netherlands. MATERIALS: 28 patients with MEN 2 who underwent total adrenalectomy for phaeochromocytoma between 1972 and 1996. MAIN OUTCOME MEASURES: Perioperative morbidity and mortality, histopathological findings, complications of adrenocortical supplementation therapy.
RESULTS: 22 patients had bilateral phaeochromocytomas on histopathological examination (79%) and 6 patients had initially unilateral phaeochromocytomas There was no operative mortality or substantial morbidity except for one splenic injury that necessitated splenectomy. During a mean follow-up period of 14 years (range 1-26) nine patients (32%) had a total of 19 Addisonian crises that necessitated admission to hospital. One patient died of an unrecognised Addisonian crisis.
CONCLUSION: Complications of adrenocortical supplementation therapy are considerable, but they can be reduced when unilateral adrenalectomy is done for a unilateral phaeochromocytoma in patients with MEN 2 syndrome, provided that they are carefully followed up.

Entities:  

Mesh:

Year:  1999        PMID: 10533758     DOI: 10.1080/11024159950189320

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  6 in total

1.  Outcomes and timing for intervention of partial adrenalectomy in patients with a solitary adrenal remnant and history of bilateral phaeochromocytomas.

Authors:  Thomas H Sanford; Benjamin Barckley Storey; William Marston Linehan; Craig A Rogers; Peter A Pinto; Gennady Bratslavsky
Journal:  BJU Int       Date:  2010-08-19       Impact factor: 5.588

2.  Outcome of surgery for primary hyperaldosteronism.

Authors:  Jens Waldmann; Lisa Maurer; Julia Holler; Peter H Kann; Annette Ramaswamy; Detlef K Bartsch; Peter Langer
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

Review 3.  Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.

Authors:  Samuel A Wells; Furio Pacini; Bruce G Robinson; Massimo Santoro
Journal:  J Clin Endocrinol Metab       Date:  2013-06-06       Impact factor: 5.958

4.  Pheochromocytoma management, outcomes and the role of cortical preservation.

Authors:  Alisha Gupta; Sandeep Agarwala; Nikhil Tandon; M Srinivas; Minu Bajpai; Devendra Kumar Gupta; Arun Kumar Gupta; Chandersekhar Bal; Rakesh Kumar; Veereshwar Bhatnagar
Journal:  Indian J Pediatr       Date:  2013-11-08       Impact factor: 1.967

5.  Painful Hip Leading to the Diagnosis of MEN 2B Syndrome.

Authors:  Mehtab Ahmad; Imran Rizvi; Amit Jain; Noorin Zaidi
Journal:  Case Rep Endocrinol       Date:  2012-11-26

Review 6.  Early identification of patients with von Hippel-Lindau disease at risk for pheochromocytoma.

Authors:  J K Maranchie; M M Walther
Journal:  Curr Urol Rep       Date:  2001-02       Impact factor: 2.862

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.